Hardy, Richard R.
Fox Chase Cancer Center,
United States
2025 Rank: 20567
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 711 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20567 | 22910 |
| Total Cites | 19331 | 21008 |
| H-index | 70 | 72 |
| Hm-index | 23 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 407 | 414 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 4132 | 4288 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 7334 | 7782 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14216 | 14982 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.40 |
| Self-Citation Percentage |
7.98%
|
|
Hardy, Richard R.
Fox Chase Cancer Center,
United States
2024 Rank: 17663
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 629 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17663 | 19731 |
| Total Cites | 18992 | 20681 |
| H-index | 70 | 73 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 400 | 407 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 4205 | 4370 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 7477 | 7938 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 13812 | 14574 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.42 |
| Self-Citation Percentage |
8.17%
|
|
Hardy, Richard R.
Fox Chase Cancer Center,
United States
2023 Rank: 16926
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 615 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16926 | 18635 |
| Total Cites | 18174 | 19838 |
| H-index | 69 | 72 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 383 | 390 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 4096 | 4260 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 7298 | 7756 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 13118 | 13859 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.43 |
| Self-Citation Percentage |
8.39%
|
|
Hardy, Richard R.
Fox Chase Cancer Center,
United States
2022 Rank: 15254
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 581 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15254 | 16854 |
| Total Cites | 17372 | 19013 |
| H-index | 69 | 72 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 371 | 378 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 3984 | 4146 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 7093 | 7540 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 12440 | 13170 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.44 |
| Self-Citation Percentage |
8.63%
|
|
Hardy, Richard R.
Fox Chase Cancer Center,
United States
2021 Rank: 14565
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 554 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14565 | 16100 |
| Total Cites | 16883 | 18514 |
| H-index | 68 | 71 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 360 | 367 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 3903 | 4065 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 6940 | 7387 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 12041 | 12759 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.45 |
| Self-Citation Percentage |
8.81%
|
|
Hardy, Richard R.
Fox Chase Cancer Center,
United States
2020 Rank: 12972
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 490 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12972 | 14722 |
| Total Cites | 15788 | 17372 |
| H-index | 68 | 70 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 347 | 354 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 3790 | 3954 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 6712 | 7159 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 11114 | 11803 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.47 |
| Self-Citation Percentage |
9.12%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.